http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170142635-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5db290e32b898d96dc1a2f0359fd3a23 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-328 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-332 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R1-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 |
| filingDate | 2016-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e634096a8c66b7e7d5f7e65aac8b40f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a79624c454e66505857688e7d02e0ba |
| publicationDate | 2017-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20170142635-A |
| titleOfInvention | Novel strains of Bacillus licheniformis NY1505 producing high amount of α-glucosidase inhibitors |
| abstract | The present invention provides a strain of Bacillus licheniformis NY1505 ( Bacillus licheniformis NY1505, accession number KCTC13021BP) that highly produces an α-glucosidase inhibitor. The strain Bacillus licheniformis NY1505 according to the present invention is a novel strain capable of living under anaerobic conditions and produces an? -Glucosidase inhibitor in the intestines. Therefore, it maintains an effective concentration constantly, and thus can exhibit excellent weight loss and hypoglycemic effect And exhibits the characteristics of being inhabited temporarily but not in the intestine, and the α-glucosidase inhibitor produced by the strain or strain administered as needed can be discharged and used safely. In addition, a separate fermentation cost and processing cost are not required for the production of the? -Glucosidase inhibitor, so that the production cost can be reduced, and problems such as fermentation can be avoided and the present invention can be applied to various types of foods. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220045692-A |
| priorityDate | 2016-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 202.